​

Danaher (DHR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DHR Stock Forecast

Danaher (DHR) stock forecast, based on 43 Wall Street analysts, predicts a 12-month average price target of $238.77, with a high of $275.00 and a low of $195.00. This represents a 3.59% increase from the last price of $230.50.

$175 $195 $215 $235 $255 $275 High: $275 Avg: $238.77 Low: $195 Last Closed Price: $230.5

DHR Stock Rating

Danaher stock's rating consensus is Buy, based on 43 Wall Street analysts. The breakdown includes 1 Strong Buy (2.33%), 30 Buy (69.77%), 11 Hold (25.58%), 1 Sell (2.33%), and 0 Strong Sell (0.00%).

Buy
Total 43 1 11 30 1 Strong Sell Sell Hold Buy Strong Buy

DHR Price Target Upside V Benchmarks

TypeNameUpside
StockDanaher3.59%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks1.63%

Price Target Trends

1M3M12M
# Anlaysts7829
Avg Price Target$255.57$254.88$239.93
Last Closing Price$230.50$230.50$230.50
Upside/Downside10.88%10.58%4.09%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 265173--25
Sep, 265174--26
Aug, 265174--26
Jul, 264184--26
Jun, 264192--25
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 22, 2026Douglas SchenkelUBS$260.00$233.5711.32%12.80%
Oct 22, 2026Goldman Sachs$275.00$234.0917.48%19.31%
Oct 22, 2026Robert W. Baird$254.00$234.098.51%10.20%
Oct 22, 2026Barclays$260.00$234.0911.07%12.80%
Oct 12, 2026Kallum TitchmarshMorgan Stanley$240.00$220.248.97%4.12%
Oct 05, 2026Dan LeonardRBC Capital$250.00$214.0616.79%8.46%
Oct 01, 2026Subbu NambiGuggenheim$250.00$220.3413.46%8.46%
Sep 09, 2026Douglas SchenkelUBS$250.00$205.2021.83%8.46%
Jul 22, 2026Justin BowersDeutsche Bank$240.00$175.0337.12%4.12%
Jul 22, 2026RBC Capital$215.00$179.1420.02%-6.72%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 22, 2026UBSBuyBuyhold
Oct 22, 2026Goldman SachsBuyBuyhold
Oct 22, 2026CitigroupBuyBuyhold
Oct 22, 2026BarclaysOverweightOverweighthold
Oct 13, 2026Cowen & Co.BuyBuyhold
Oct 12, 2026Morgan StanleyOverweightOverweighthold
Oct 05, 2026RBC CapitalOutperformOutperformhold
Oct 01, 2026GuggenheimBuyBuyhold
Jul 22, 2026Deutsche BankBuyBuyhold
Jul 22, 2026Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

$5 $6 $7 $8 $9 $10 $11 $12 $13 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$8.77$9.80$6.44$5.33$5.07----
Avg Forecast$8.77$9.41$7.43$7.50$7.99$8.94$10.05$11.00$11.54
High Forecast$8.95$9.80$7.48$7.54$8.38$9.92$10.38$11.47$12.04
Low Forecast$8.62$9.13$7.38$7.46$7.81$8.32$9.71$10.74$11.27
Surprise %-4.14%-13.32%-28.93%-36.55%----

Revenue Forecast

$24B $25B $27B $29B $31B $33B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$29.45B$26.64B$23.89B$23.88B$24.57B----
Avg Forecast$29.25B$30.97B$27.12B$23.79B$24.41B$26.21B$27.99B$29.69B$31.82B
High Forecast$29.71B$31.96B$27.40B$23.86B$24.94B$27.91B$28.01B$30.67B$32.87B
Low Forecast$28.85B$30.26B$26.97B$23.73B$23.87B$25.49B$27.97B$29.15B$31.24B
Surprise %0.69%-13.96%-11.90%0.37%0.66%----

Net Income Forecast

$3B $4B $5B $7B $8B $9B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$6.43B$7.21B$4.76B$3.90B$3.61B----
Avg Forecast$6.52B$3.80B$4.20B$5.53B$5.97B$6.72B$7.41B$8.11B$8.51B
High Forecast$6.65B$4.56B$5.04B$5.56B$6.18B$7.31B$7.65B$8.46B$8.87B
Low Forecast$6.40B$3.04B$3.36B$5.50B$5.76B$6.13B$7.16B$7.92B$8.30B
Surprise %-1.31%89.61%13.43%-29.53%-39.46%----

DHR Forecast FAQ

Is Danaher stock a buy?

Danaher stock has a consensus rating of Buy, based on 43 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 30 Buy, 11 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Danaher is a favorable investment for most analysts.

What is Danaher's price target?

Danaher's price target, set by 43 Wall Street analysts, averages $238.77 over the next 12 months. The price target range spans from $195 at the low end to $275 at the high end, suggesting a potential 3.59% change from the previous closing price of $230.5.

How does Danaher stock forecast compare to its benchmarks?

Danaher's stock forecast shows a 3.59% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (1.63%).

What is the breakdown of analyst ratings for Danaher over the past three months?

  • October 2026: 20.00% Strong Buy, 68.00% Buy, 12.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 19.23% Strong Buy, 65.38% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 19.23% Strong Buy, 65.38% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.

What is Danaher’s EPS forecast?

Danaher's average annual EPS forecast for its fiscal year ending in December 2026 is $8.94, marking a 76.33% increase from the reported $5.07 in 2025. Estimates for the following years are $10.05 in 2027, $11 in 2028, and $11.54 in 2029.

What is Danaher’s revenue forecast?

Danaher's average annual revenue forecast for its fiscal year ending in December 2026 is $26.21B, reflecting a 6.68% increase from the reported $24.57B in 2025. The forecast for 2027 is $27.99B, followed by $29.69B for 2028, and $31.82B for 2029.

What is Danaher’s net income forecast?

Danaher's net income forecast for the fiscal year ending in December 2026 stands at $6.72B, representing an 86.04% increase from the reported $3.61B in 2025. Projections indicate $7.41B in 2027, $8.11B in 2028, and $8.51B in 2029.